Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15... Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders. Show more
MIAMI, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk (NYSE: NVO). As the weight loss...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -19.96 | -18.3186490455 | 108.96 | 109.88 | 81.5 | 14644448 | 90.70015397 | CS |
4 | -16.31 | -15.4876080144 | 105.31 | 112.52 | 81.5 | 7378787 | 99.22072656 | CS |
12 | -28.59 | -24.3132919466 | 117.59 | 120.56 | 81.5 | 6020298 | 106.2781403 | CS |
26 | -52.83 | -37.2488190087 | 141.83 | 148.15 | 81.5 | 4922728 | 117.71761215 | CS |
52 | -13.74 | -13.3735643372 | 102.74 | 148.15 | 81.5 | 4658482 | 120.83816286 | CS |
156 | 34.675 | 63.8288080994 | 54.325 | 148.15 | 45.755 | 2830195 | 100.4773849 | CS |
260 | 59.99 | 206.790761806 | 29.01 | 148.15 | 24.62 | 2179536 | 86.06181887 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales